Sign in
4

Changes in Ownership

Lipocine Inc. Filed Acc 0001638599-21-000537

Options or other derivatives

  • Director acquired 22,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Fink Jeffrey Arvin Director 2021-06-09 Grant or award · Stock Option (Right to Buy) +22,000 $1.26 $27,720 22,000 D
Loading xslF345X03/doc4_7259.xml…